Drug Reference

Emtricitabine / Rilpivirine / Tenofovir Alafenamide

Antivirals for treatment of HIV infections, combinations

Fact box

Therapeutic class: Antivirals for treatment of HIV infections, combinations

Brand names

Odefsey

Available as

200 MG · Oral Tablet

Multi-ingredient product

EmtricitabineRilpivirineTenofovir Alafenamide

This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.

Current FDA labels (DailyMed)

ODEFSEY (EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE) TABLET [GILEAD SCIENCES, INC.]
ODEFSEY (EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE) TABLET [A-S MEDICATION SOLUTIONS]

2 marketed products on record (RxNorm)

Authoritative sources

DailyMed — current FDA labeling →
LactMed — breastfeeding safety (NLM) →
MedlinePlus — plain-language drug info →
RxNorm (NLM) →

Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.